210 related articles for article (PubMed ID: 32757799)
1. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
Gabr JB; Bilal H; Mirchia K; Perl A
J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
[TBL] [Abstract][Full Text] [Related]
2. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
[TBL] [Abstract][Full Text] [Related]
3. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.
Morales E; Rabasco C; Gutierrez E; Praga M
Transpl Int; 2015 Jul; 28(7):878-80. PubMed ID: 25712140
[No Abstract] [Full Text] [Related]
4. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
Ng JY; Lenton D; Kerridge I; Wong C
J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
[TBL] [Abstract][Full Text] [Related]
5. Approaching treatment of transplant-associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus.
Jan AS; Hosing C; Aung F; Yeh J
Transfusion; 2019 Nov; 59(11):3519-3524. PubMed ID: 31587288
[TBL] [Abstract][Full Text] [Related]
6. The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.
Bjørkto MH; Barratt-Due A; Nordøy I; Dörje C; Galteland E; Lind A; Hilli A; Aukrust P; Mjøen G
BMC Infect Dis; 2021 Feb; 21(1):137. PubMed ID: 33526010
[TBL] [Abstract][Full Text] [Related]
7. Eculizumab deposits in vessel walls in thrombotic microangiopathy.
Cassol CA; Brodsky SV; Satoskar AA; Blissett AR; Cataland S; Nadasdy T
Kidney Int; 2019 Sep; 96(3):761-768. PubMed ID: 31345584
[TBL] [Abstract][Full Text] [Related]
8. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
[TBL] [Abstract][Full Text] [Related]
9. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
Kello N; Khoury LE; Marder G; Furie R; Zapantis E; Horowitz DL
Semin Arthritis Rheum; 2019 Aug; 49(1):74-83. PubMed ID: 30598332
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis.
Øzbay LA
Clin J Gastroenterol; 2020 Jun; 13(3):344-348. PubMed ID: 31612381
[TBL] [Abstract][Full Text] [Related]
11. Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature.
Zafar A; Lim MY; Abou-Ismail MY
Thromb Res; 2023 Apr; 224():73-79. PubMed ID: 36871347
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
Wright RD; Bannerman F; Beresford MW; Oni L
BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
[TBL] [Abstract][Full Text] [Related]
13. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
[TBL] [Abstract][Full Text] [Related]
14. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.
Merola J; Yoo PS; Schaub J; Smith JD; Rodriguez-Davalos MI; Tichy E; Mulligan DC; Asch W; Formica R; Kashgarian M; Kulkarni S
Transplant Proc; 2016 Nov; 48(9):3106-3108. PubMed ID: 27932157
[TBL] [Abstract][Full Text] [Related]
15. Primary antiphospholipid syndrome presented as thrombotic microangiopathy in renal transplantation.
Bada-Bosch T; Redondo B; Sevillano AM; Alonso M; Trujillo H; Auñón P; Polanco N; Rodríguez L; Gonzalez E; Andrés A
Nefrologia (Engl Ed); 2020; 40(1):108-110. PubMed ID: 31431303
[No Abstract] [Full Text] [Related]
16. Eculizumab therapy.
Cataland SR
Biol Blood Marrow Transplant; 2014 Apr; 20(4):438-9. PubMed ID: 24534107
[No Abstract] [Full Text] [Related]
17. Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
Fujita Y; Terashita M; Yazawa M; Yamasaki Y; Imamura T; Kibayashi J; Sawai T; Hidaka Y; Ohtani K; Inoue N; Shibagaki Y
Intern Med; 2020; 59(1):93-99. PubMed ID: 31902910
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
[TBL] [Abstract][Full Text] [Related]
19. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
[TBL] [Abstract][Full Text] [Related]
20. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
